Page results
-
Thalassaemia is a group of inherited blood conditions where the part of the blood known as haemoglobin is abnormal.
-
UCLH is a designated Haemophilia Centre providing a 24/7 service for patients, including those needing treatment with blood products and clotting factor medications.
-
The bone marrow transplant and haematopoietic stem cell transplant service at UCLH is the largest in Europe and provides a full range of transplant services.
-
UCLH is a centre of excellence in the management of patients with acute and chronic leukaemia.
-
UCLH is a centre of excellence in the management of patients with acute and chronic leukaemia. We provide an advanced diagnostic service and a comprehensive treatment programme for patients with different types of leukaemia.
-
We provide an advanced diagnostic service and a comprehensive treatment programme for patients with different types of leukaemia.
-
UCLH provides an advanced diagnostic service and a comprehensive treatment programme for patients with different types of leukaemia.
-
Patient information which describes what miscarriages are, and why they occur, explains what treatment options are available, describes expectant management in detail, explains what can be expected during your recovery from a miscarriage and discusses future pregnancies.
-
UCLH treats a range of red cell blood disorders and anaemias.
-
Anaemia is a condition in which the body has fewer red blood cells, or have less haemoglobin in the red blood cells, than normal. Patients who may have anaemia can be referred to general haematology by GPs and hospital doctors.
File results
-
FOI2017182 Cancer patients treated with certain drugs
-
FOI2017186 Cyber security and cyber attacks
-
FOI2017188 Thefts from patients
-
FOI2017189 Cost and number of tattoos removed
-
Charity Matters magazine - Winter 2020
-
FOI2017190 Consultants undertaking private work
-
FOI2017193 Risk management information
-
FOI/2024/0481 - Maternity unit closed to new admissions 2018-2023
-
FOI/2023/0461 - UCLH operating system software/ data centres hybrid cloud
-
FOI/2023/0459 - Multiple myeloma treatment